Biotech / Investors
Biotech organisations are looking for funding to develop their innovations, and Investors are looking for good investments. Pharmora can help both.
Clinical Development - With our understanding of the biotech industry, gained from years of supporting clinical development...
from the early phases to late stage, filing and beyond, Pharmora can help you to develop your innovations.
Starting prior to the First in Human studies we can:
- Review the non-clinical data package
- Advise on the Clinical Development Programme and Target Product Profile (TPP)
- Write clinical study protocols, including integrating patients into the design of clinical trials as appropriate
- Help design data collection forms and other study documentation
- Review the data from your clinical trials to:
- Monitor patient safety (Read a case study here)
- Improve data accuracy (Read a case study here)
- Protect your trial from unnecessary suspension (Read a case study here)
- Support you throughout the clinical development process and beyond (Read a case study here)
Due Diligence - If you are an Investor seeking to understand the data package for an asset, Pharmora can review the Virtual Data Room and produce a Due Diligence report...
summarising the contents and outlining the key points. We will flag any questions or concerns for you and provide a list of suggested questions to facilitate your discussions, so that you can decide whether or not to invest your precious funds in the asset.
Preparing for investment decisions - If you are a Biotech company seeking your next round of funding, Pharmora can help you...
to generate the data packages you need to present for the next milestone decisions. Using our experience of assessing data on behalf of Regulatory Agencies and Investors, Pharmora can review your documentation and advise on any potential gaps or likely questions that an investor may have. We can help you address any potential concerns so that Investors can see the true value in your assets.
If you are looking to sell your product we can create a “Development Overview” for you to provide to potential investors to help orientate them around your data during their Due Diligence activities.